The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-3-Hydroxy-2-(4-hydroxyphenyl)-N-(1-phenylpropyl)quinoline-4-carboxamide ID: ALA3815072
PubChem CID: 136094790
Max Phase: Preclinical
Molecular Formula: C25H22N2O3
Molecular Weight: 398.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC[C@H](NC(=O)c1c(O)c(-c2ccc(O)cc2)nc2ccccc12)c1ccccc1
Standard InChI: InChI=1S/C25H22N2O3/c1-2-20(16-8-4-3-5-9-16)27-25(30)22-19-10-6-7-11-21(19)26-23(24(22)29)17-12-14-18(28)15-13-17/h3-15,20,28-29H,2H2,1H3,(H,27,30)/t20-/m0/s1
Standard InChI Key: TXDBXQBOYJCRTB-FQEVSTJZSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
-1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2907 -2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2489 -3.5938 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5870 -3.7544 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5812 -5.2552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2768 -5.9975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2409 -5.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8775 -6.0115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8739 -7.5115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1711 -8.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4720 -7.5180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4757 -6.0180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1785 -5.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9086 1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2125 0.7617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5065 1.5203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4965 3.0203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1925 3.7616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8985 3.0029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6486 -1.3517 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.5317 3.6272 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
1 10 1 0
5 10 1 0
11 12 2 0
11 13 1 0
4 11 1 0
14 15 1 1
15 16 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
14 17 1 0
13 14 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
23 28 2 0
2 23 1 0
3 29 1 0
26 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 398.46Molecular Weight (Monoisotopic): 398.1630AlogP: 5.19#Rotatable Bonds: 5Polar Surface Area: 82.45Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.06CX Basic pKa: 2.83CX LogP: 5.94CX LogD: 5.86Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.43Np Likeness Score: -0.53
References 1. Yamamoto K, Okazaki S, Ohno H, Matsuda F, Ohkura S, Maeda K, Fujii N, Oishi S.. (2016) Development of novel NK3 receptor antagonists with reduced environmental impact., 24 (16): [PMID:27298001 ] [10.1016/j.bmc.2016.05.054 ]